SUBJECT TO COMPLETION DATED MARCH 2, 2021
PROSPECTUS
ION Geophysical Corp.
Rights to Purchase up to
$52,500,000 in (i) Aggregate Principal Amount of
8.00% Senior Secured Second Priority Convertible Notes Due 2025,
(ii) Shares of Common Stock, or (iii) a Combination Thereof.
We are distributing, at no charge, to holders of our Common Stock, on a pro-rata basis, non-transferable subscription rights (the “Rights”) to purchase up to $52,500,000 in (i) aggregate principal amount of our 8.00% Senior Secured Second Priority Convertible Notes due 2025 (the “Notes”), (ii) shares of ION Common Stock, or (iii) a combination thereof. We refer to the offering of these securities through the Rights as the “Rights Offering.” Only holders of our Common Stock at 5:00 p.m., New York City time, on , 2021, which we refer to as the “Record Date,” will receive one Right for each share of Common Stock owned. Each Right will entitle a holder to purchase (i) a principal amount of our Notes equal to $50,000,000 divided by the number of shares of our Common Stock outstanding as of the Record Date, at a purchase price of 100% of the principal amount thereof or (ii) a number of shares of our Common Stock equal to $50,000,000 divided by the purchase price of $2.57 per share divided by the number of shares of our Common Stock outstanding as of the Record Date, at a purchase price of $2.57 per whole share of Common Stock; provided that any Notes will only be issued in minimum increments of $1,000 and any exercise of Rights therefor will be rounded down to the nearest whole increment of $1,000 and any shares of Common Stock will only be issued in whole numbers of shares with any fractional shares of our Common Stock rounded down to the nearest whole share. As of March 2, 2021, we had 17,693,405 shares of Common Stock outstanding such that each Right would entitle a holder to purchase (i) $2.78 principal amount of our Notes or (ii) 1.08 shares of our Common Stock (such amounts to be updated based on the number of shares of Common Stock outstanding on the Record Date). You will be entitled to an over-subscription privilege to purchase additional securities that may remain unsubscribed as a result of any unexercised Rights, such privilege being referred to as the “Over-Subscription Privilege.”
The Notes will accrue interest at the rate of 8.0% per annum, mature on December 15, 2025, be secured on a second-priority basis, subject to liens securing ION’s obligations under its existing credit agreement, and unconditionally guaranteed by certain ION subsidiaries. Holders of the Notes may convert all or any portion of their notes at their option at any time prior to the maturity date. The initial conversion price of the Notes shall be $3.00 per share and is subject to adjustment as described in this Prospectus. ION will have the right, on or after the 18 month anniversary of the issue date, to convert all or part of the outstanding Notes if ION’s Common Stock has a 20 trading day VWAP of at least 175% of the conversion price then in effect, which would currently equal $5.25 per share. The Notes will be redeemable, in whole or in part, at our option at any time prior to December 15, 2023, at a cash redemption price equal to 100.0% of the principal amount of Notes to be redeemed plus a make-whole premium and accrued and unpaid interest. The Notes will also be redeemable, in whole or in part, at our option at any time on or after December 15, 2023, at a cash redemption price equal to 100.0% of the principal amount of Notes to be redeemed plus accrued and unpaid interest. If a Change of Control (as described in this Prospectus) occurs, Holders of the Notes may require us to repurchase their Notes at a cash repurchase price equal to 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest. Holders of the Notes will also be entitled to certain voting rights and the right to designate two independent directors to ION’s Board of Directors.
Pursuant to the terms of this Rights Offering, the Rights may be exercised for a maximum of $52,500,000 of Notes and Common Stock (the “Maximum Offering Amount”). In connection with the Rights Offering, as of March 2, 2021 we have entered into backstop agreements (the “Backstop Agreements”) with several parties (the “Backstop Providers”) pursuant to which the Backstop Providers have agreed, in the aggregate, to purchase in excess of $20,000,000 of Notes at par or shares of Common Stock at $2.57 per share (the “Backstop Commitment”). The Backstop Agreements are subject to customary terms and conditions, including payment, in principal amount of Notes or shares of Common Stock at $2.57 per share, of a backstop fee in an amount up to five percent (5%) of the Backstop Commitment. To complete the Rights Offering and effect the Restructuring Transactions, we must receive net proceeds of at least $20,000,000 from the Rights Offering. The current Backstop Commitment will allow us to satisfy this condition. We have engaged Oppenheimer & Co. Inc. to act as dealer manager (“Dealer Manager”) for this Rights Offering.
If the Rights Offering is not fully subscribed and you fully exercise your basic subscription rights, you may also exercise the Over-Subscription Privilege to purchase securities that were not subscribed for by other stockholders under the Rights Offering, subject to proration as described herein. The Rights will expire if they are not exercised by 5:00 p.m., New York City time, on , 2021 unless we extend the Rights Offering period (the “Expiration Date”). We may extend the Rights Offering and the period for exercising your Rights, in our sole discretion, up to an additional ( ) days.
Concurrent with the Rights Offering, we are conducting an offer to exchange (the “Exchange Offer”) all outstanding $120.6 million aggregate principal amount of our 9.125% Senior Secured Second Priority Notes due 2021 (the “Existing Second Lien Notes”), with each $1,000 principal amount of such notes tendered exchanged for (a) $150 in cash and (b) $850 of new Notes identical to the Notes offered in this Rights Offering, subject to certain rights to instead deliver or receive Common Stock, plus payment of all accrued and unpaid interest (the “Exchange Consideration”). Holders who validly tender (and do not validly withdraw) their Existing Second Lien notes at or prior to , 2021 (the “Early Tender Time”), will be eligible to receive $35, at the Company’s option, either in (I) cash, (II) Common Stock, based on $2.57 per share, or (III) new Notes identical to the Notes offered in this Rights Offering, per $1,000 principal amount of Existing Second Lien Notes tendered, in addition to the Exchange Consideration (the “Early Participation Payment”). In connection with the Exchange Offer, we have entered into a Restructuring Support Agreement, as amended and restated, (the “Restructuring Support Agreement”) with approximately 90% of the holders of the Existing Second Lien Notes (the “Supporting Noteholders”) pursuant to which we have committed to use our reasonable efforts to effect the Rights Offering and the Exchange Offer (the “Restructuring Transactions”) and the Supporting Noteholders have committed to tender the Existing Second Lien Notes held by such holders in the Exchange Offer. We have also entered into a letter agreement with Mr. James M. Lapeyre, Jr. (the “Lapeyre Letter Agreement”), pursuant to which Mr. Lapeyre has agreed to tender his Existing Second Lien Notes in the Exchange Offer as a part of the Restructuring Transactions. As a result, approximately 92% of the holders of our Existing Second Lien Notes have agreed to tender their notes in the Exchange Offer. The Exchange Offer is subject to the satisfaction or waiver of certain conditions, as described below, including that the Rights Offering generate net proceeds to the Company of at least $20 million. If the Exchange Offer is not completed, we will not complete the Rights Offering.
The Notes will not be listed for trading on any exchange, but the Notes will be transferable until three days prior to their maturity. We cannot give you any assurance that a market for the Notes will develop or, if a market does develop, of the price at which the Notes will trade or whether such market will be sustainable throughout the period when the Notes are transferable.
Our Common Stock is quoted on the NYSE, under the symbol “IO.” On March 1, 2021, the last reported price of our Common Stock on the NYSE was $3.12 per share.
| | | Per share of Common Stock | | | Total Shares(2) | | | Per Note | | | Total Notes(2) | |
Subscription price(1) | | | | $ | | | | | | $ | | | | | | $ | | | | | | $ | | | |
Proceeds to us | | | | $ | | | | | | $ | | | | | | $ | | | | | | $ | | | |
(1)
Based on shares of Common Stock outstanding as on March , 2021
(2)
Assumes the Rights Offering is fully subscribed.
Our board of directors is making no recommendation regarding your exercise of the Rights. You should carefully consider whether to exercise your Rights before the expiration date. You may not revoke or revise any exercises of Rights once made unless we terminate the Rights Offering.
Investing in our securities involves a high degree of risk. You should carefully review the risks and uncertainties described under the heading “Risk Factors” beginning on page 13 of this Prospectus and in any other document incorporated by reference herein or therein before you make an investment in our securities. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this Prospectus. Any representation to the contrary is a criminal offense.
Dealer Manager
Oppenheimer & Co. Inc.
The date of this Prospectus is , 2021.